Literature DB >> 9417175

Cardiovascular malformations and complications in Turner syndrome.

V P Sybert1.   

Abstract

BACKGROUND: Turner syndrome (gonadal dysgenesis with sex chromosome abnormalities) is recognized to be a disorder in which cardiovascular malformations are common. The prevalence and natural history of these findings, the risk for aortic dissection, and the occurrence of cardiovascular disease have all been the subject of debate, as have been the American Academy of Pediatrics recommendations for cardiac screening of patients with Turner syndrome.
OBJECTIVE: To evaluate a large population of patients both cross-sectionally and longitudinally to determine the prevalence of cardiovascular malformations, the risk for dissection of the aorta, to determine whether there are phenotype:karyotype correlations that can allow for specific recommendations, and to devise an appropriate screening protocol. DESIGN AND METHODS: Data have been collected for patients with Turner syndrome. These individuals have been seen in an ongoing clinic established for the study of the natural history of Turner syndrome. Data from physical examinations, evaluations by cardiologists, echocardiography results, medical and surgical complications, medical records, and causes of death were analyzed. A total of 244 of 462 individuals in this population with karyotype-proven Turner syndrome could be evaluated because echocardiograms had been obtained. In addition, the medical literature was reviewed for occurrences of aortic dissection in patients with Turner syndrome.
RESULTS: A total of 136 (56%) of 244 of these patients had cardiovascular abnormalities, 96 (71%) were structural, 40 (29%) were functional, including hypertension (HBP), mitral valve prolapse and conduction defects. Coarctation of the aorta and bicuspid aortic valve, alone or in combination, comprised >50% of the cardiac malformations. Bicuspid valve was often not detected by examination, but only by echocardiography. Aortic dissection occurred in three of the patients. In one, it was traumatic; in a second, it occurred at the site of coarctation repair. The third patient had long-standing HBP with malignant obesity. In the literature, there have been 42 case reports of aortic dissection in Turner syndrome. In all except 5, predisposing risk factors of coarctation, bicuspid aortic valve, and/or HBP were present. Of these 5, sufficient information regarding predisposing risk factors was provided for only 2. No phenotype:karyotype correlations could be drawn with any certainty.
CONCLUSIONS: When the diagnosis of Turner syndrome is made, a screening echocardiogram should be obtained. Referral to a cardiologist first may be appropriate, but physical examination does not substitute for visualization. Individuals with and without evidence of structural cardiac malformations should be monitored for HBP on a lifelong basis. In the absence of structural cardiac malformations or HBP, the risk for aortic dissection appears small, and repeated echocardiography or magnetic resonance imaging to follow aortic root diameters does not appear to be warranted based on data currently available. Protocols for following patients with structural malformations need to be individualized, and wholesale recommendations have little merit. A longitudinal study using magnetic resonance imaging or cardiac echocardiography to establish normal parameters for aortic root diameters and to follow aortic root changes is needed.

Entities:  

Mesh:

Year:  1998        PMID: 9417175     DOI: 10.1542/peds.101.1.e11

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  44 in total

1.  Prevalence of associated cardiovascular abnormalities in 500 patients with aortic coarctation referred for cardiovascular magnetic resonance imaging to a tertiary center.

Authors:  Lynette L S Teo; Tim Cannell; Sonya V Babu-Narayan; Marina Hughes; Raad H Mohiaddin
Journal:  Pediatr Cardiol       Date:  2011-04-22       Impact factor: 1.655

2.  Management of patients with bicuspid aortic valve disease.

Authors:  Todd L Kiefer; Andrew Wang; G Chad Hughes; Thomas M Bashore
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 3.  Optimising management in Turner syndrome: from infancy to adult transfer.

Authors:  M D C Donaldson; E J Gault; K W Tan; D B Dunger
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

4.  Turner syndrome - an accidental finding?

Authors:  Nighat Butt; Robin W Paton
Journal:  Ann R Coll Surg Engl       Date:  2008-03       Impact factor: 1.891

5.  Intervention and management of congenital left heart obstructive lesions.

Authors:  Amy Schimke; Arjun Majithia; Robert Baumgartner; Amy French; David Goldberg; Jeffrey Kuvin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 6.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

7.  Genetic issues in the care of the adolescent patient.

Authors:  Lea Velsher
Journal:  Paediatr Child Health       Date:  2003-01       Impact factor: 2.253

8.  Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature.

Authors:  M Carlson; M Silberbach
Journal:  BMJ Case Rep       Date:  2009-07-01

Review 9.  Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature.

Authors:  M Carlson; M Silberbach
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

10.  Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study.

Authors:  Britta E Hjerrild; Kristian H Mortensen; Keld E Sørensen; Erik M Pedersen; Niels H Andersen; Erik Lundorf; Klavs W Hansen; Arne Hørlyck; Alfred Hager; Jens S Christiansen; Claus H Gravholt
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.